Net profit of Tatva Chintan Pharma Chem reported to Rs 9.92 crore in the quarter ended September 2025 as against net loss of Rs 0.66 crore during the previous quarter ended September 2024. Sales rose 47.95% to Rs 123.52 crore in the quarter ended September 2025 as against Rs 83.49 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales123.5283.49 48 OPM %17.986.68 - PBDT22.725.79 292 PBT13.66-1.02 LP NP9.92-0.66 LP Powered by Capital Market - Live News

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live News

Tatva Chintan Pharma Chem announced that the Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News

Net profit of Tatva Chintan Pharma Chem rose 27.64% to Rs 6.65 crore in the quarter ended June 2025 as against Rs 5.21 crore during the previous quarter ended June 2024. Sales rose 10.81% to Rs 116.86 crore in the quarter ended June 2025 as against Rs 105.46 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales116.86105.46 11 OPM %14.8311.97 - PBDT18.0713.47 34 PBT9.106.81 34 NP6.655.21 28 Powered by Capital Market - Live News

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 24 July 2025.Powered by Capital Market - Live News